439 related articles for article (PubMed ID: 11984607)
1. Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine.
Kohler KA; Banerjee K; Gary Hlady W; Andrus JK; Sutter RW
Bull World Health Organ; 2002; 80(3):210-6. PubMed ID: 11984607
[TBL] [Abstract][Full Text] [Related]
2. Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.
Samoilovich EO; Feldman EV; Yermalovich MA; Protas II; Titov LP
Cent Eur J Public Health; 2003 Dec; 11(4):213-8. PubMed ID: 14768785
[TBL] [Abstract][Full Text] [Related]
3. Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91.
Andrus JK; Strebel PM; de Quadros CA; Olivé JM
Bull World Health Organ; 1995; 73(1):33-40. PubMed ID: 7704923
[TBL] [Abstract][Full Text] [Related]
4. Poisson-model analysis of the risk of vaccine-associated paralytic poliomyelitis in Japan between 1971 and 2000.
Hao L; Toyokawa S; Kobayashi Y
Jpn J Infect Dis; 2008 Mar; 61(2):100-3. PubMed ID: 18362395
[TBL] [Abstract][Full Text] [Related]
5. Paralytic poliomyelitis associated with Sabin monovalent and bivalent oral polio vaccines in Hungary.
Estívariz CF; Molnár Z; Venczel L; Kapusinszky B; Zingeser JA; Lipskaya GY; Kew OM; Berencsi G; Csohán A
Am J Epidemiol; 2011 Aug; 174(3):316-25. PubMed ID: 21685412
[TBL] [Abstract][Full Text] [Related]
6. Cost analysis of post-polio certification immunization policies.
Sangrujee N; Cáceres VM; Cochi SL
Bull World Health Organ; 2004 Jan; 82(1):9-15. PubMed ID: 15106295
[TBL] [Abstract][Full Text] [Related]
7. A developing country perspective on vaccine-associated paralytic poliomyelitis.
John TJ
Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
[TBL] [Abstract][Full Text] [Related]
8. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
Chowdhary R; Dhole TN
J Med Virol; 2008 Aug; 80(8):1477-88. PubMed ID: 18551602
[TBL] [Abstract][Full Text] [Related]
9. Vaccine-associated paralytic poliomyelitis in the postelimination era in Latin America and the Caribbean, 1992-2011.
Landaverde JM; Trumbo SP; Danovaro-Holliday MC; Cochi SE; Gandhi R; Ruiz-Matus C
J Infect Dis; 2014 May; 209(9):1393-402. PubMed ID: 24520126
[TBL] [Abstract][Full Text] [Related]
10. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
[TBL] [Abstract][Full Text] [Related]
11. Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis.
Strebel PM; Ion-Nedelcu N; Baughman AL; Sutter RW; Cochi SL
N Engl J Med; 1995 Feb; 332(8):500-6. PubMed ID: 7830731
[TBL] [Abstract][Full Text] [Related]
12. Vaccine-associated paralytic poliomyelitis in the Russian Federation in 1998-2014.
Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Korotkova EA; Kozlovskaya LI; Baykova OY; Krasota AY; Gmyl AP
Int J Infect Dis; 2018 Nov; 76():64-69. PubMed ID: 30201507
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of alternative polio immunization policies in South Africa.
Griffiths UK; Botham L; Schoub BD
Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
[TBL] [Abstract][Full Text] [Related]
14. [Paralytic poliomyelitis in Russian Federation in 1998-2005].
Ivanova OE; Eremeeva TP; Leshchinskaia EV; Korotkova EA; Iakovenko ML; Cherniavskaia OP; Cherkasova EA; Dragunskaia EM; Dekonenko EP; Martynenko IN; Krasnoproshina LI; Sorokina MP
Zh Mikrobiol Epidemiol Immunobiol; 2007; (5):37-44. PubMed ID: 18038545
[TBL] [Abstract][Full Text] [Related]
15. Vaccine-associated paralytic poliomyelitis: a retrospective cohort study of acute flaccid paralyses in Brazil.
de Oliveira LH; Struchiner CJ
Int J Epidemiol; 2000 Aug; 29(4):757-63. PubMed ID: 10922356
[TBL] [Abstract][Full Text] [Related]
16. Vaccine policy changes and epidemiology of poliomyelitis in the United States.
Alexander LN; Seward JF; Santibanez TA; Pallansch MA; Kew OM; Prevots DR; Strebel PM; Cono J; Wharton M; Orenstein WA; Sutter RW
JAMA; 2004 Oct; 292(14):1696-701. PubMed ID: 15479934
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of clincal poliomyelitis in Shandong Province from 1993-1996].
Lei J; Li L; Xu A
Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Dec; 19(6):327-9. PubMed ID: 10921114
[TBL] [Abstract][Full Text] [Related]
18. Recipient vaccine-associated paralytic poliomyelitis in China, 2010-2015.
Wu W; Wang H; Li K; Pekka Nuorti J; Liu D; Xu D; Ye J; Zheng J; Fan C; Wen N; An Z
Vaccine; 2018 Feb; 36(9):1209-1213. PubMed ID: 29395524
[TBL] [Abstract][Full Text] [Related]
19. Imported vaccine-associated paralytic poliomyelitis--United States, 2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Feb; 55(4):97-9. PubMed ID: 16456525
[TBL] [Abstract][Full Text] [Related]
20. Polio eradication: the OPV paradox.
Dowdle WR; De Gourville E; Kew OM; Pallansch MA; Wood DJ
Rev Med Virol; 2003; 13(5):277-91. PubMed ID: 12931339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
